Drug class
First-generation piperazine antihistamine; H1 receptor antagonist with antiemetic effects
Mechanism of action
Antagonises central and peripheral histamine H1 receptors and has anticholinergic activity, reducing vestibular stimulation and emetic signalling.
General use cases
- Prevention and symptomatic treatment of nausea, vomiting and motion sickness in countries where buclizine products are authorised; product-specific age and route restrictions apply
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
